Fabio Tettamanzi

  • Citations Per Year
Learn More
Background B490 (EudraCT# 2011-002564-24) is a randomized, phase 2b, noninferiority study investigating the efficacy and safety of first-line cetuximab plus cisplatin with/without paclitaxel (CetCis(More)
  • 1